The percentage of cells staining with PD-L1, CD8, 4-1BB, and granzyme B plus perforin in patients with disease control and disease progression from melanoma (n=28) and NSCLC cohorts (n=13) are shown in Figure 2A and Supplementary Table S5. This evidence concerns the gene CD274 and non-small cell lung carcinoma.